RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance

Autor:	Tamara C. Stegmann, Masja de Haas, Dian Winkelhorst, Sietse Q. Nagelkerke, Taco W. Kuijpers, Barbera Veldhuisen, Esther P. Verduin, Gestur Vidarsson, C. Ellen van der Schoot, Henk Schonewille
Přispěvatelé:	Other departments, Amsterdam institute for Infection and Immunity, General Paediatrics, Paediatric Infectious Diseases / Rheumatology / Immunology, Landsteiner Laboratory
Rok vydání:	2017
Předmět:	Adult 0301 basic medicine Erythrocytes Rho(D) Immune Globulin Immunology RhD antigen Biology Polymorphism Single Nucleotide Biochemistry Erythroblastosis Fetal 03 medical and health sciences 0302 clinical medicine Gene Frequency Isoantibodies Pregnancy medicine Humans Red blood cell clearance Treatment Failure Receptor Fetus Rh-Hr Blood-Group System Receptors IgG Infant Newborn Case-control study Cell Biology Hematology Middle Aged medicine.disease Red blood cell 030104 developmental biology medicine.anatomical_structure Case-Control Studies Female 030215 immunology Clearance
Zdroj:	Blood, 129(8), 1045-1048. American Society of Hematology
ISSN:	1528-0020 0006-4971
Popis:	To the editor: Red blood cell (RBC) alloimmunization against the RhD antigen may occur in RhD-negative women during pregnancy or at delivery of a RhD-positive child.[1][1] The administration of Rh-immunoglobulin (Rh-Ig) prevents anti-D alloimmunization and subsequent hemolytic disease of the fetus
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c2720425b850a5ccfdac09973ab260 https://doi.org/10.1182/blood-2016-05-716365 Zobrazit plný text záznamu